| OFVIX | RMEBX | OFVIX / RMEBX | |
| Total Expense Ratio | 0.55 | 1.07 | 51% |
| Annual Report Gross Expense Ratio | 0.55 | 1.07 | 51% |
| Fund Existence | 10 years | 12 years | - |
| Gain YTD | 14.006 | 9.416 | 149% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 250 | 4,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 287M | 118B | 0% |
| Annual Yield % from dividends | 1.57 | 0.99 | 159% |
| Returns for 1 year | 5.10 | 8.96 | 57% |
| Returns for 3 years | 28.69 | 32.63 | 88% |
| Returns for 5 years | 32.28 | 36.13 | 89% |
| Returns for 10 years | 131.34 | 90.64 | 145% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIDG | 10.45 | 0.67 | +6.85% |
| Leverage Shares 2X Long BIDU Daily ETF | |||
| BIS | 14.02 | 0.49 | +3.65% |
| ProShares UltraShort Nasdaq Biotech | |||
| HIPS | 11.46 | N/A | N/A |
| GraniteShares HIPS US High Income ETF | |||
| IGF | 66.81 | -0.19 | -0.28% |
| iShares Global Infrastructure ETF | |||
| ILTB | 47.18 | -0.22 | -0.46% |
| iShares Core 10+ Year USD Bond ETF | |||